The protein Hck is a member of the Src family of non-receptor tyrosine
kinases which is preferentially expressed in haematopoietic cells of
the myeloid and B-lymphoid lineages(1,2). Src kinases are inhibited by
tyrosine-phosphorylation at a carboxy-terminal site(3-9). The SH2 dom
ains of these enzymes play an essential role in this regulation by bin
ding to the tyrosine-phosphorylated tail(8-11). The crystal structure
of the downregulated form of Hck has been determined(12) and reveals t
hat the SH2 domain regulates enzymatic activity indirectly; intramolec
ular interactions between the SH3 and catalytic domains appear to stab
ilize an inactive form of the kinase, Here we compare the roles of the
SH2 and SH3 domains in modulating the activity of Hck in an investiga
tion of the C-terminally phosphorylated form of the enzyme, We show th
at addition of the HIV-1 Nef protein, which is a high-affinity ligand
for the Hck SH3 domain, to either the downregulated or activated form
of Hck causes a large increase in Hck catalytic activity, The intact S
H3-binding motif in Nef is crucial for Hck activation. Our results ind
icate that binding of the Hck SH3 domain by Nef causes a more marked a
ctivation of the enzyme than does binding of the SH2 domain, suggestin
g a new mechanism for regulation of the activity of tyrosine kinases.